Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-24 @ 7:38 PM
NCT ID:
NCT02267603
Brief Title:
Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Official Title:
A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)
Study:
NCT02267603
Protocol Section:
NCT02267603